Reckitt Benckiser Group PLC (LON:RB) Rating Restated
Today, Kepler Cheuvreux reiterated their Buy rating on Reckitt Benckiser Group PLC (LON:RB)’s stock in a research report revealed to clients and investors.
LON:RB is currently trading 1.23% higher at GBX 7423.00 as of 01:29 London time. Reckitt Benckiser Group PLC’s stock is up 19.98% in the past 200 days. It has outperformed the S&P 500 Index, which has increased 2.61% in the same time.
According to data compiled by Thomson Reuters, Reckitt Benckiser Group PLC (LON:RB)’s stock is covered by 20 equity analysts across the Street, with 1 analysts giving it a Sell rating, 13 a Buy rating, while 9 consider it a Hold. The 12-month consensus target price for the stock is GBX 7549.15, which reflects an upside potential of 1.70% over the current price.
LON:RB Price Chart & Trend
The stock price of Reckitt Benckiser Group PLC has increased 19.98% over the last 200 days, and is in powerful up trend. In the last 50 and 100 days, Reckitt Benckiser Group PLC is up 0.88% and up 7.29%, respectively. Our stocks momentum model is shown on the price chart below.
Reckitt Benckiser Group PLC (LON:RB) Profile
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA, DvM and Food. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand.
Reckitt Benckiser Group PLC (LON:RB) traded up 1.23% on 14 October, hitting GBX 7423. A total of 115,585 shares of the company’s stock traded hands. This is down from average of 1.26 million shares. Reckitt Benckiser Group PLC has a 52 week low of GBX 5839.08 and a 52 week high of GBX 7786. The company has a market cap of 52.16 billion GBX and a P/E ratio of 34.21.
Get the latest Reckitt Benckiser Group PLC (LON:RB) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
Reckitt Benckiser Group PLC - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.